BROWN MORGAN R — SEC insider filings
SEC reporting owner CIK 1266062. 16 insider filings on record with FilingPulse; latest filed 2026-10-21.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2020-12-08 to 2026-10-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 25,687 shares, $38,414 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: sale of 17,250 shares @ $1.57 ($27,024) in Lipocine Inc., filed 2020-12-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Lipocine Inc. (LPCN) | Chief Financial Officer | 3 | — | 2 legs · 25,687 sh · $38,414 | 8 |
| Clene Inc. (CLNN) | Chief Financial Officer | 13 | — | — | 13 |
Insider filings — BROWN MORGAN R
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-21 | 4 | Clene Inc. (CLNN) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Clene Inc. (CLNN) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | Clene Inc. (CLNN) | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2025-09-30 | 4/A | Clene Inc. (CLNN) | Holdings only — no transactions reported | EDGAR |
| 2025-09-29 | 4 | Clene Inc. (CLNN) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-09-19 | 4 | Clene Inc. (CLNN) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-02-25 | 4 | Clene Inc. (CLNN) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2024-08-19 | 4 | Clene Inc. (CLNN) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | Clene Inc. (CLNN) | Grant/award (A): 400,000 (derivative) @ $0 · Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2023-07-03 | 4 | Clene Inc. (CLNN) | Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2023-02-21 | 4 | Clene Inc. (CLNN) | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2022-11-07 | 4 | Clene Inc. (CLNN) | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2022-02-03 | 4 | Clene Inc. (CLNN) | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2021-12-08 | 4 | Lipocine Inc. (LPCN) | Grant/award (A): 176,000 (derivative) @ $1.12 | EDGAR |
| 2020-12-17 | 4 | Lipocine Inc. (LPCN) | Option exercise (M): 28,125 @ $0 · Sale (S): 8,437 @ $1.35 · Grant/award (A): 160,000 (derivative) @ $1.37 · Option exercise (M): 28,125 (derivative) @ $0 | EDGAR |
| 2020-12-08 | 4 | Lipocine Inc. (LPCN) | Option exercise (M): 57,500 @ $0 · Sale (S): 17,250 @ $1.57 · Option exercise (M): 70,754 @ $0 · Option exercise (M): 57,500 (derivative) @ $0 · Option exercise (M): 70,754 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-12-02 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1266062 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs